KORU Medical Systems (NASDAQ:KRMD - Get Free Report) is expected to announce its earnings results after the market closes on Wednesday, March 12th. Analysts expect KORU Medical Systems to post earnings of ($0.04) per share for the quarter. Investors that are interested in participating in the company's conference call can do so using this link.
KORU Medical Systems Price Performance
Shares of KORU Medical Systems stock remained flat at $3.16 on Friday. The stock had a trading volume of 138,579 shares, compared to its average volume of 209,436. The stock's fifty day moving average is $4.03 and its 200 day moving average is $3.37. The company has a debt-to-equity ratio of 0.01, a quick ratio of 2.37 and a current ratio of 2.99. KORU Medical Systems has a 1-year low of $2.04 and a 1-year high of $5.05. The company has a market capitalization of $144.84 million, a P/E ratio of -12.64 and a beta of 0.74.
Analyst Ratings Changes
A number of brokerages have commented on KRMD. Lake Street Capital increased their price objective on shares of KORU Medical Systems from $4.00 to $5.00 and gave the company a "buy" rating in a research report on Tuesday, January 14th. Piper Sandler reiterated a "neutral" rating and set a $4.50 target price on shares of KORU Medical Systems in a research note on Friday, February 14th. Canaccord Genuity Group raised their price target on KORU Medical Systems from $3.00 to $4.00 and gave the company a "buy" rating in a research note on Thursday, November 14th. Finally, Craig Hallum upped their price objective on KORU Medical Systems from $5.00 to $6.00 and gave the stock a "buy" rating in a research report on Friday, January 17th. One investment analyst has rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Buy" and a consensus price target of $4.70.
Get Our Latest Stock Analysis on KRMD
KORU Medical Systems Company Profile
(
Get Free Report)
KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.
Featured Stories

Before you consider KORU Medical Systems, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and KORU Medical Systems wasn't on the list.
While KORU Medical Systems currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.